IS5471A - Aðferð til framleiðslu á afleiðum af taxóíða flokknum - Google Patents

Aðferð til framleiðslu á afleiðum af taxóíða flokknum

Info

Publication number
IS5471A
IS5471A IS5471A IS5471A IS5471A IS 5471 A IS5471 A IS 5471A IS 5471 A IS5471 A IS 5471A IS 5471 A IS5471 A IS 5471A IS 5471 A IS5471 A IS 5471A
Authority
IS
Iceland
Prior art keywords
producing derivatives
taxoid class
taxoid
class
derivatives
Prior art date
Application number
IS5471A
Other languages
English (en)
Other versions
IS2272B (is
Inventor
Didier Eric
Oddon Gilles
Pauze Denis
Leon Patrick
Riguet Didier
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of IS5471A publication Critical patent/IS5471A/is
Publication of IS2272B publication Critical patent/IS2272B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5471A 1997-11-18 2000-04-26 Aðferð til framleiðslu á afleiðum af taxóíða flokknum IS2272B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714442A FR2771092B1 (fr) 1997-11-18 1997-11-18 Procede de preparation de derives de la classe des taxoides
PCT/FR1998/002432 WO1999025704A1 (fr) 1997-11-18 1998-11-16 Procede de preparation de derives de la classe des taxoides

Publications (2)

Publication Number Publication Date
IS5471A true IS5471A (is) 2000-04-26
IS2272B IS2272B (is) 2007-07-15

Family

ID=9513490

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5471A IS2272B (is) 1997-11-18 2000-04-26 Aðferð til framleiðslu á afleiðum af taxóíða flokknum

Country Status (44)

Country Link
US (1) US5962705A (is)
EP (1) EP1032565B1 (is)
JP (1) JP4359386B2 (is)
KR (1) KR100581656B1 (is)
CN (1) CN100375744C (is)
AP (1) AP1198A (is)
AR (1) AR017639A1 (is)
AT (1) ATE232855T1 (is)
AU (1) AU755376B2 (is)
BG (1) BG64281B1 (is)
BR (1) BRPI9814658B8 (is)
CA (1) CA2304833C (is)
CO (1) CO4771105A1 (is)
CZ (1) CZ292642B6 (is)
DE (1) DE69811530T2 (is)
DK (1) DK1032565T3 (is)
DZ (1) DZ2653A1 (is)
EA (1) EA002622B1 (is)
EE (1) EE04277B1 (is)
ES (1) ES2192795T3 (is)
FR (1) FR2771092B1 (is)
GE (1) GEP20022822B (is)
HU (1) HU228188B1 (is)
ID (1) ID24620A (is)
IL (1) IL135512A (is)
IN (1) IN191018B (is)
IS (1) IS2272B (is)
MA (1) MA24817A1 (is)
MX (1) MXPA00002244A (is)
MY (1) MY121031A (is)
NO (1) NO325664B1 (is)
NZ (1) NZ504125A (is)
OA (1) OA11384A (is)
PL (1) PL191240B1 (is)
PT (1) PT1032565E (is)
SI (1) SI1032565T1 (is)
SK (1) SK283932B6 (is)
TN (1) TNSN98207A1 (is)
TR (1) TR200001415T2 (is)
TW (1) TW518329B (is)
UA (1) UA56275C2 (is)
UY (1) UY25256A1 (is)
WO (1) WO1999025704A1 (is)
ZA (1) ZA9810511B (is)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6403634B1 (en) 1999-01-13 2002-06-11 Aventis Pharma S.A. Use of taxoid derivatives
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
JP5588983B2 (ja) 2008-08-11 2014-09-10 ウェルズ ファーゴ バンク ナショナル アソシエイション マルチアームポリマーアルカノエートコンジュゲート
DK2493466T3 (da) 2009-10-29 2021-04-26 Sanofi Mature Ip Hidtil ukendt antitumoral anvendelse af cabazitaxel
US8791279B2 (en) 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
US20130338216A1 (en) 2010-12-22 2013-12-19 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
KR20140018917A (ko) 2011-04-12 2014-02-13 플러스 케미칼스, 에스.에이. 카바지탁셀의 고상 형태 및 이의 제조 방법
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103012330A (zh) * 2011-09-23 2013-04-03 复旦大学 一种紫杉醇类抗癌药xrp6258的制备方法
CN103012329A (zh) * 2011-09-23 2013-04-03 复旦大学 一种制备紫杉醇类抗癌药Cabazitaxel XRP6258的方法
WO2013069027A1 (en) 2011-09-26 2013-05-16 Fresenius Kabi Oncology Ltd. Processes for the preparation of cabazitaxel involving c(7) -oh and c(13) -oh silylation or just c(7) -oh silylation
CN102408397B (zh) * 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN102516281B (zh) * 2011-10-20 2015-02-04 江苏红豆杉生物科技股份有限公司 一种10-脱乙酰基巴卡丁iii及其衍生物甲氧基化的方法
CN103906747A (zh) 2011-10-31 2014-07-02 台湾神隆股份有限公司 卡巴他赛及其中间体的制备方法
CN103159704B (zh) * 2011-12-12 2015-06-10 上海佰霖国际贸易有限公司 卡巴他赛中间体及卡巴他赛中间体的制备方法
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
WO2013111157A1 (en) 2012-01-03 2013-08-01 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
CN102786502B (zh) * 2012-08-21 2014-05-14 江苏红豆杉生物科技有限公司 一种紫杉烷药物7,10-甲氧基多西他赛的合成方法
WO2014072996A2 (en) 2012-11-09 2014-05-15 Intas Pharmaceuticals Limited Process for the preparation of cabazitaxel and its intermediates
KR101407353B1 (ko) 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103012331A (zh) * 2012-12-28 2013-04-03 北京科莱博医药开发有限责任公司 卡巴他赛及其中间体的制备方法
WO2014199401A2 (en) * 2013-06-14 2014-12-18 Hetero Research Foundation Process for cabazitaxel
CN106632158B (zh) * 2013-08-28 2018-11-06 江苏恒瑞医药股份有限公司 7β,10β-二甲氧基-10-去乙酰基浆果赤霉素III的制备方法
CN103450117A (zh) * 2013-09-18 2013-12-18 江苏红豆杉药业有限公司 一种7,10-二甲氧基紫杉烷化合物的制备方法
KR101490738B1 (ko) 2013-10-15 2015-02-11 (주)한국해양기상기술 플랑크톤 검사장치
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
CN105121419B (zh) * 2013-12-24 2016-08-03 于跃 Cabazitaxel类抗多药耐药紫杉烷类抗肿瘤化合物及其制备方法
CN104817522A (zh) * 2015-04-01 2015-08-05 江苏红豆杉药业有限公司 一种7,10-二甲氧基-10DabⅢ的合成方法
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927118A (en) * 1973-12-21 1975-12-16 Crown Zellerbach Corp Process for monoetherification of polyhydric benzenes
EP0304244A3 (en) * 1987-08-18 1990-01-10 Takeda Chemical Industries, Ltd. Propanediol derivatives, their production and use
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) * 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
GB9405400D0 (en) * 1994-03-18 1994-05-04 Erba Carlo Spa Taxane derivatives
WO1995029926A1 (en) * 1994-04-28 1995-11-09 Allelix Biopharmaceuticals Inc. Guanidino-substituted compounds
IT1274250B (it) * 1995-02-21 1997-07-15 Himont Inc Dieteri utilizzabili nella preparazione di catalizzatori ziegler-natta
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis

Also Published As

Publication number Publication date
IL135512A (en) 2004-06-20
DE69811530T2 (de) 2003-10-02
AP1198A (en) 2003-08-27
FR2771092B1 (fr) 1999-12-17
HUP0100519A1 (hu) 2001-06-28
CA2304833A1 (fr) 1999-05-27
ID24620A (id) 2000-07-27
JP2001523673A (ja) 2001-11-27
EE200000155A (et) 2001-06-15
BRPI9814658B8 (pt) 2021-05-25
TNSN98207A1 (fr) 2005-03-15
OA11384A (fr) 2004-01-27
ES2192795T3 (es) 2003-10-16
SK7102000A3 (en) 2000-11-07
MY121031A (en) 2005-12-30
TR200001415T2 (tr) 2001-01-22
JP4359386B2 (ja) 2009-11-04
EA002622B1 (ru) 2002-06-27
IS2272B (is) 2007-07-15
US5962705A (en) 1999-10-05
EA200000539A1 (ru) 2000-12-25
HU228188B1 (en) 2013-01-28
BRPI9814658B1 (pt) 2016-07-19
CA2304833C (fr) 2007-03-27
SK283932B6 (sk) 2004-05-04
PL191240B1 (pl) 2006-04-28
AU1242299A (en) 1999-06-07
BG104455A (en) 2001-02-28
NZ504125A (en) 2002-10-25
AP2000001816A0 (en) 2000-06-30
PT1032565E (pt) 2003-07-31
WO1999025704A1 (fr) 1999-05-27
EE04277B1 (et) 2004-04-15
MXPA00002244A (es) 2002-04-24
DE69811530D1 (de) 2003-03-27
NO20002443L (no) 2000-05-11
HUP0100519A3 (en) 2002-09-30
MA24817A1 (fr) 1999-12-31
UA56275C2 (uk) 2003-05-15
CZ20001789A3 (cs) 2000-11-15
CZ292642B6 (cs) 2003-11-12
UY25256A1 (es) 2001-08-27
CN1270586A (zh) 2000-10-18
EP1032565B1 (fr) 2003-02-19
CN100375744C (zh) 2008-03-19
SI1032565T1 (en) 2003-06-30
EP1032565A1 (fr) 2000-09-06
IL135512A0 (en) 2001-05-20
CO4771105A1 (es) 1999-04-30
KR100581656B1 (ko) 2006-05-23
AU755376B2 (en) 2002-12-12
DK1032565T3 (da) 2003-06-02
IN191018B (is) 2003-09-13
KR20010032138A (ko) 2001-04-16
GEP20022822B (en) 2002-10-25
PL340579A1 (en) 2001-02-12
TW518329B (en) 2003-01-21
DZ2653A1 (fr) 2003-03-15
ZA9810511B (en) 1999-05-25
BR9814658A (pt) 2000-10-03
AR017639A1 (es) 2001-09-12
ATE232855T1 (de) 2003-03-15
BG64281B1 (bg) 2004-08-31
FR2771092A1 (fr) 1999-05-21
NO20002443D0 (no) 2000-05-11
NO325664B1 (no) 2008-07-07

Similar Documents

Publication Publication Date Title
IS5471A (is) Aðferð til framleiðslu á afleiðum af taxóíða flokknum
IS5473A (is) Aðferð til framleiðslu á sítalóprami
IS2256B (is) Aðferð til framleiðslu á sítalóprami
IS2697B (is) Aðferð til framleiðslu á sítalóprami
IS5862A (is) Aðferð til framleiðslu á sítalóprami
IS2343B (is) Aðferð til framleiðslu á sítalóprami
DK0885968T3 (da) Fremgangsmåde til fremstilling af vanillin
IS8368A (is) Ný aðferð
BR9806033B1 (pt) relógio.
NO20003139L (no) FremgangsmÕte for syntese av 1,3-dioler
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
DE69823658D1 (de) Ein laser
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0905254T3 (da) Fremgangsmåde til fremstilling af en lavemolekylær
DK1065938T3 (da) Fremgangsmåde til fremstilling af et smøremateriale
EE200000140A (et) Asendatud kromaani derivaadid
EE200000144A (et) Asendatud kromaani derivaadid
IS5106A (is) Ný aðferð
NO20000574D0 (no) Trinnstyrt frekvens-syntetisator
DE69830200D1 (de) Verdampfungsprozess
DE69720520D1 (de) Taktgenerator
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
IS2260B (is) Aðferð til framleiðslu á sítalóprami
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer